Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:IMGN

ImmunoGen (IMGN) Stock Price, News & Analysis

ImmunoGen logo

About ImmunoGen Stock (NASDAQ:IMGN)

Advanced Chart

Key Stats

Today's Range
$31.23
$31.23
50-Day Range
$31.23
$31.23
52-Week Range
$3.61
$31.25
Volume
40 shs
Average Volume
8.78 million shs
Market Capitalization
$8.32 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive IMGN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ImmunoGen and its competitors with MarketBeat's FREE daily newsletter.

IMGN Stock News Headlines

WARNING: A Digital Dollar Is Still In The Works
A digital dollar could theoretically be used as a surveillance tool for banks, federal agencies, and the Federal Reserve.
Artisan International Small-Mid Instl
Artisan International Small-Mid Advisor
See More Headlines

IMGN Stock Analysis - Frequently Asked Questions

ImmunoGen, Inc. (NASDAQ:IMGN) announced its quarterly earnings data on Monday, July, 31st. The biotechnology company reported ($0.02) earnings per share for the quarter, beating analysts' consensus estimates of ($0.16) by $0.14. ImmunoGen's revenue for the quarter was up 485.9% compared to the same quarter last year.
Read the conference call transcript
.

ImmunoGen subsidiaries include Hurricane LLC, ImmunoGen BioPharma (Ireland) Limited, ImmunoGen Europe Limited, and ImmunoGen Securities Corp..

Based on aggregate information from My MarketBeat watchlists, some other companies that ImmunoGen investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Advanced Micro Devices (AMD), GE Aerospace (GE), Arista Networks (ANET) and Adobe (ADBE).

Company Calendar

Last Earnings
7/31/2023
Today
7/09/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:IMGN
CIK
855654
Employees
277
Year Founded
1981

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
390.38
P/E Growth
N/A
Net Income
-$222.93 million
Pretax Margin
-25.24%

Debt

Sales & Book Value

Annual Sales
$287.61 million
Price / Cash Flow
N/A
Book Value
$0.71 per share
Price / Book
43.99

Miscellaneous

Free Float
252,764,000
Market Cap
$8.32 billion
Optionable
Optionable
Beta
1.18

Social Links

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NASDAQ:IMGN) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners